Tazorac Gel
Product Images NDC 16110-042

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Tazorac (NDC 16110-042). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Almirall, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula For Tazarotene Is A Member Of The Acetylenic Class Of Retinoids. Chemically, Tazarotene Is Ethyl 6-[(4,4-dimethylthiochroman-6-yl)ethynyl]nicotinate. The Compound Has An Empirical Formula Of C21h21no2s And Molecular Weight Of 351.46. (Tazorac Gel 01)

FDA Label Image

0.05% 30 G Tube Label (Tazorac Gel 02)

TAZORAC is a prescription-only topical gel for dermatologic use containing tazarotene at a concentration of 0.05%. The gel also contains several inactive ingredients such as ascorbic acid, water and preservatives like benzyl alcohol. The drug is stored at room temperature and should be kept out of reach of children. The tube comes with included patient information that should be read before use. TAZORAC is a registered trademark of Almiral LLC and should not be used for any other purpose than what is instructed in the patient information. The medicine is distributed by Almiral LLC in the USA and comes with an NDC number and an expiration date stamped on the crimp of the tube. This drug is not intended for ophthalmic use.*

FDA Label Image

0.05% 30 G Tube Carton Label (Tazorac Gel 03)

TAZORAC is a gel medication containing 0.05% Tazarotene which is used once daily (in the evening) to cover psoriatic lesions. It should be applied only to affected skin and should not cover more than 20% of the body or come in contact with unaffected skin. The gel contains Benzyl alcohol 1% (w/w) as a preservative with other inactive ingredients. The recommended storage temperature is at or below 25°C (77°F) and it should be kept out of reach of children. The medicine is distributed by Almirall, LLC, and is made in the USA. An individual should consult a physician's order for detailed information about the medication.*

FDA Label Image

0.05% 100 G Tube Label (Tazorac Gel 04)

This is a description of Tazorac Gel, containing Tazarotene 0.05% as an active ingredient and Benzyl alcohol 1% as a preservative. It is meant to be used for treating psoriasis. It's applied once a day at night using enough to cover the lesion but not more than 20% of the body surface area. Before application, the skin should be dry and untreated skin should be avoided. It's manufactured and distributed by Almirall, LLC, Exton, PA 19341, USA. You should keep this and all drugs out of the reach of children.*

FDA Label Image

0.05% 100 G Tube Carton Label (Tazorac Gel 05)

TAZORAC gel is a prescription medication with Tazarotene as its active ingredient. It is used once a day in the evening to treat psoriasis on the skin. A thin layer of the gel should be applied to affected areas. It should not be applied to unaffected skin. The ingredients include benzyl alcohol, glycols, poloxamer, and purified water. It should be stored at temperatures between 15 and 30 degrees Celsius. This medication is distributed by Almirall, LLC, Exton, PA 19341, USA. Almirall® and its design are trademarks of Almirall, Inc.*

FDA Label Image

0.1% 30 G Tube Label (Tazorac Gel 06)

TAZORAC® (fazarotene) gel is a topical medication used for dermatologic use only and is not for ophthalmic use. Its main active ingredient is Tazarotene with a concentration of 0.1%. Other ingredients include ascorbic acid, butylated hydroxyanisole, butylated hydroxytoluene, carbomer, edetate disodium, hexylene glycol, poloxamer 407, polyethylene glycol 400, polysorbate 40, purified water, and tromethamine. The drug is distributed by Almirall, LLC, and its trademark is registered to the same company. The medication should be stored below room temperature and kept out of reach of children. Additional information can be found on the accompanying patent seal and complete prescribing information.*

FDA Label Image

0.1% 30 G Tube Carton Label (Tazorac Gel 07)

TAZORAC® (tazarotene) gel is a medication that can be applied to the skin to treat acne and psoriasis. It should be applied once a day, in the evening, to the affected area only, and after cleansing and drying the skin. The prescription drug should be used with caution and as directed, as it may cause skin irritation. The gel contains several ingredients, including tazarotene, benzyl alcohol, and purified water, among others. TAZORAC® should be stored at room temperature and kept out of reach of children. This information is provided by the manufacturer, Almirall.*

FDA Label Image

0.1% 100 G Tube Label (Tazorac Gel 08)

TAZORAC® is a gel medication indicated for patients with psoriasis or acne. Its active ingredient is Tazarotene 0.1% and its preservative is Benzyl alcohol 1%. Other inactive ingredients include Ascorbic acid, carbomer homopolymer type B, and purified water. Patients should apply the gel once a day in the evening to affected areas of the skin using enough to cover no more than 20% of body surface area. It should not be applied to unaffected skin. The patient should see the crimp of the tube for lot number and expiration date. The drug should be stored at temperatures between 16-30°C (53-86°F) and should be kept out of reach of children. This medication is distributed by Almirall, LLC, Exton, PA 19341, USA.*

FDA Label Image

0.1% 100 G Tube Carton Label (Tazorac Gel 09)

TAZORAC® is a trademarked acne medicine available in gel form, containing 0.1% tazarotene and 1% benzyl alcohol. The gel should only be applied to dry skin, once-a-day, in the evening, covering the affected area; no more than 20% of the body's surface area should be covered. The medicine should not be applied to eyes, mouth, angles of the nose, or mucous membranes, and people younger than 12 years should not use it. The gel should be stored at room temperature (25°C or an excusion 15-30°C), away from children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.